CERENOME, INC. — Form 8-K
Filed August 4, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 12/100
What the filing says
Plus Therapeutics, Inc. changed its legal name to Cerenome, Inc. effective August 3, 2026. The Board of Directors approved the amendment on June 26, 2026, and updated bylaws were adopted. No financial transactions, counterparties, or material operational changes are disclosed in this filing.
Why this rating
Pure corporate rebranding is administrative; no financial impact, no M&A, no operational change disclosed. Routine for small cap.
See more from August 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.